$PGNY
Progyny, Inc.

2021 Q4 Form 10-K Financial Statement

#000155837022002466 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $127.6M $122.3M $500.6M
YoY Change 27.17% 23.61% 45.17%
Cost Of Revenue $102.4M $93.79M $388.5M
YoY Change 28.63% 20.1% 41.37%
Gross Profit $25.12M $28.49M $112.1M
YoY Change 21.53% 36.74% 60.06%
Gross Profit Margin 19.69% 23.3% 22.4%
Selling, General & Admin $25.30M $19.43M $79.80M
YoY Change 29.73% 21.36% 29.3%
% of Gross Profit 100.75% 68.18% 71.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $316.0K $267.0K $1.301M
YoY Change -32.77% -41.96% -31.74%
% of Gross Profit 1.26% 0.94% 1.16%
Operating Expenses $25.30M $19.43M $79.80M
YoY Change 29.73% 21.36% 29.3%
Operating Profit -$188.0K $9.065M $32.34M
YoY Change -116.19% 87.76% 287.4%
Interest Expense $83.00K $144.0K $461.0K
YoY Change 361.0%
% of Operating Profit 1.59% 1.43%
Other Income/Expense, Net -$210.0K $52.00K $95.00K
YoY Change -1500.0% -966.67% -71.3%
Pretax Income -$398.0K $9.117M $32.44M
YoY Change -133.84% 89.07% 273.72%
Income Tax -$15.48M -$7.679M -$33.33M
% Of Pretax Income -84.23% -102.77%
Net Earnings $15.08M $16.80M $65.77M
YoY Change -61.4% 248.32% 41.56%
Net Earnings / Revenue 11.82% 13.74% 13.14%
Basic Earnings Per Share $0.17 $0.19 $0.74
Diluted Earnings Per Share $0.15 $0.17 $0.66
COMMON SHARES
Basic Shares Outstanding 90.54M 89.57M 89.11M
Diluted Shares Outstanding 100.3M 100.4M 100.4M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.4M $114.3M $119.4M
YoY Change 9.26% 8.87% 9.26%
Cash & Equivalents $91.41M $92.22M $91.41M
Short-Term Investments $28.01M $22.09M $28.01M
Other Short-Term Assets $4.564M $4.933M $4.564M
YoY Change -13.89% 279.46% -13.89%
Inventory
Prepaid Expenses
Receivables $134.6M $135.2M $134.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $258.5M $254.4M $258.5M
YoY Change 35.91% 37.82% 35.93%
LONG-TERM ASSETS
Property, Plant & Equipment $5.027M $4.702M $12.83M
YoY Change 47.85% 34.34% 6.05%
Goodwill $11.88M $11.88M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.941M $1.101M $74.22M
YoY Change 413.26% 83.5% 92.77%
Total Long-Term Assets $99.53M $82.26M $99.53M
YoY Change 56.23% 370.05% 56.24%
TOTAL ASSETS
Total Short-Term Assets $258.5M $254.4M $258.5M
Total Long-Term Assets $99.53M $82.26M $99.53M
Total Assets $358.1M $336.7M $358.1M
YoY Change 41.01% 66.59% 41.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $61.40M $55.43M $61.40M
YoY Change 41.1% 31.34% 41.15%
Accrued Expenses $37.43M $49.06M $35.25M
YoY Change 23.11% 53.31% 15.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $98.82M $104.5M $98.82M
YoY Change 27.05% 40.81% 27.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.419M $438.0K $7.419M
YoY Change 746.92% -27.0% -19.36%
Total Long-Term Liabilities $7.419M $438.0K $7.419M
YoY Change 746.92% -27.0% -19.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $98.82M $104.5M $98.82M
Total Long-Term Liabilities $7.419M $438.0K $7.419M
Total Liabilities $106.2M $112.6M $106.2M
YoY Change 22.15% 50.49% 22.12%
SHAREHOLDERS EQUITY
Retained Earnings -$2.424M -$17.50M
YoY Change -96.45%
Common Stock $255.3M $242.9M
YoY Change 8.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $251.8M $224.1M $251.8M
YoY Change
Total Liabilities & Shareholders Equity $358.1M $336.7M $358.1M
YoY Change 41.01% 66.59% 41.03%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income $15.08M $16.80M $65.77M
YoY Change -61.4% 248.32% 41.56%
Depreciation, Depletion And Amortization $316.0K $267.0K $1.301M
YoY Change -32.77% -41.96% -31.74%
Cash From Operating Activities $8.815M $24.16M $26.04M
YoY Change 34.99% 57.62% -28.08%
INVESTING ACTIVITIES
Capital Expenditures -$612.0K -$718.0K $2.129M
YoY Change 512.0% 378.67% 105.3%
Acquisitions
YoY Change
Other Investing Activities -$5.700M $23.09M $10.90M
YoY Change -147.54% -356.58% -127.94%
Cash From Investing Activities -$6.312M $22.37M $8.766M
YoY Change -153.09% -344.52% -121.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.314M -3.060M -13.70M
YoY Change 59.33% 90.06% 119.16%
NET CHANGE
Cash From Operating Activities 8.815M 24.16M 26.04M
Cash From Investing Activities -6.312M 22.37M 8.766M
Cash From Financing Activities -3.314M -3.060M -13.70M
Net Change In Cash -811.0K 43.48M 21.11M
YoY Change -104.96% 851.36% -309.47%
FREE CASH FLOW
Cash From Operating Activities $8.815M $24.16M $26.04M
Capital Expenditures -$612.0K -$718.0K $2.129M
Free Cash Flow $9.427M $24.88M $23.91M
YoY Change 42.19% 60.73% -32.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2019 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91088781
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001551306
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87054329
CY2019Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.22000264
CY2021 pgny Contract Term Clinics Low End Of Range
ContractTermClinicsLowEndOfRange
P1Y
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://progyny.com/20211231#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2021 pgny Noncash Interest Expense
NoncashInterestExpense
38000
CY2020 pgny Noncash Interest Expense
NoncashInterestExpense
75000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1301000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1906000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2133000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1200000
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39100
CY2021 dei Entity Registrant Name
EntityRegistrantName
Progyny, Inc.
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://progyny.com/20211231#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2220139
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1359 Broadway
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
CY2021 dei City Area Code
CityAreaCode
212
CY2021 dei Local Phone Number
LocalPhoneNumber
888-3124
CY2021 dei Security12b Title
Security12bTitle
Common Stock,
CY2021 dei Trading Symbol
TradingSymbol
PGNY
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
4100000000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91234747
CY2021 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
New York, NY
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91413000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70305000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
28005000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
38994000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17379000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9502000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
134557000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75664000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4564000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5259000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
258539000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
190222000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5027000
CY2021Q4 us-gaap Liabilities
Liabilities
106243000
CY2020Q4 us-gaap Liabilities
Liabilities
86980000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3400000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7805000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8668000
CY2021Q4 us-gaap Goodwill
Goodwill
11880000
CY2020Q4 us-gaap Goodwill
Goodwill
11880000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
599000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1213000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
71274000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37971000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2941000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
573000
CY2021Q4 us-gaap Assets
Assets
358065000
CY2020Q4 us-gaap Assets
Assets
253927000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61399000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
43514000
CY2021Q4 pgny Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
37425000
CY2020Q4 pgny Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
34272000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98824000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77786000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7419000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8318000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
876000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91088781
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87054329
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
255339000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
236139000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
615980
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
615980
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1009000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1009000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2424000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68193000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-93000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
251822000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
166947000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
358065000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
253927000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
344858000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
229683000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
388486000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
274799000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
184178000
CY2021 us-gaap Gross Profit
GrossProfit
112135000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
210000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
461000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
500621000
CY2020 us-gaap Gross Profit
GrossProfit
70059000
CY2019 us-gaap Gross Profit
GrossProfit
45505000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20179000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15006000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11901000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59616000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46705000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23927000
CY2021 us-gaap Operating Expenses
OperatingExpenses
79795000
CY2020 us-gaap Operating Expenses
OperatingExpenses
61711000
CY2019 us-gaap Operating Expenses
OperatingExpenses
35828000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
32340000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
8348000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
9677000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-366000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
121000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-58000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18176000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
95000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
331000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18234000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32435000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8679000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8557000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33334000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-37780000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
65769000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
46459000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-8569000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89105562
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85722670
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20735202
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100358047
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99055526
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20735202
CY2021 us-gaap Net Income Loss
NetIncomeLoss
65769000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
46459000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-8569000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-94000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-94000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65675000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46460000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8569000
CY2018Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
65428088
CY2018Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
106237000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-95115000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
185000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6536000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5061000
CY2019 pgny Temporary Equity Conversion To Common Stock Shares
TemporaryEquityConversionToCommonStockShares
65428088
CY2019 pgny Temporary Equity Conversion To Common Stock Value
TemporaryEquityConversionToCommonStockValue
106237000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
106237000
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
22765000
CY2019 pgny Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
62000
CY2019 pgny Underwriters Discounts And Commissions
UnderwritersDiscountsAndCommissions
5900000
CY2019 pgny Stock Offering Costs
StockOfferingCosts
3700000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
77479000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-8569000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
114271000
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-5450000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-12821000
CY2020 pgny Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0
CY2020 pgny Increase To Additional Paid In Capital Stock Issued Issuance Costs
IncreaseToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-14000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
46459000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
166947000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-14589000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33789000
CY2021 pgny Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-94000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
65769000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
251822000
CY2021 us-gaap Profit Loss
ProfitLoss
65769000
CY2020 us-gaap Profit Loss
ProfitLoss
46459000
CY2019 us-gaap Profit Loss
ProfitLoss
-8569000
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-33303000
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-37971000
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
12000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
33706000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
12821000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
5061000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9783000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5562000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1606000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18176000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
68676000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35336000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25342000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2129000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1037000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2956000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
111477000
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
103964000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-675000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
326000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4118000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17840000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25008000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3501000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2184000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
17400000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6385000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3280000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-605000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
380000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26037000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36203000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1534000
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
122372000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
64970000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
8766000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-40031000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2956000
CY2019 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
200000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8766000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40031000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2756000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
81220000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
892000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2835000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
182025000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
182278000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
185000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2924000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2329000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6536000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17966000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8930000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1347000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1244000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
62000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13695000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70305000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80382000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
91413000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70305000
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84545000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
21108000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10077000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
80255000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6249000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80382000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
176000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
204000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
24000
CY2019 pgny Noncash Or Part Noncash Deferred Initial Public Offering Costs In Accounts Payable And Accrued Liabilities Settlement Of Liability
NoncashOrPartNoncashDeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedLiabilitiesSettlementOfLiability
906000
CY2019 pgny Noncash Or Part Noncash Divesture Preferred Stock Warrant Conversion To Common Stock Warrant Upon Initial Public Offering
NoncashOrPartNoncashDivesturePreferredStockWarrantConversionToCommonStockWarrantUponInitialPublicOffering
22765000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP generally requires management to make estimates and assumptions that affect the reported amount of certain assets, liabilities, revenue, and expenses, and the related disclosure of contingent assets and liabilities. Such estimates include, but are not limited to, the determination of accrued receivables related to revenue recognition, accrued claims payable, allowance for doubtful accounts, stock-based compensation, convertible preferred stock warrant liabilities, lease liabilities, and accounting for income taxes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </p>
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8287000
CY2021 pgny Contract Term
ContractTerm
P3Y
CY2021 pgny Contract Termination Notice Period Low End Of Range
ContractTerminationNoticePeriodLowEndOfRange
P30D
CY2021 pgny Contract Termination Notice Period High End Of Range
ContractTerminationNoticePeriodHighEndOfRange
P90D
CY2021Q4 pgny Accrued Receivables
AccruedReceivables
30200000
CY2020Q4 pgny Accrued Receivables
AccruedReceivables
28200000
CY2021Q4 pgny Accrued Claims Payable Current
AccruedClaimsPayableCurrent
20000000.0
CY2020Q4 pgny Accrued Claims Payable Current
AccruedClaimsPayableCurrent
22800000
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
23700000
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
16400000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9502000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9783000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1906000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
17379000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2771000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5562000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9502000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1175000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1606000
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
10000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2771000
CY2021 pgny Contract Term Clinics High End Of Range
ContractTermClinicsHighEndOfRange
P2Y
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-style:normal;font-weight:bold;">Concentration of Credit Risk and Off-Balance-Sheet Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consists primarily of cash and cash equivalents, marketable securities, and accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company invests its cash and cash equivalents and marketable securities with highly rated financial institutions and management believes that the financial risks associated with its cash equivalents are minimal. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Substantially all of the Company’s cash is maintained with one financial institution with a high credit standing. From time to time, such deposits may exceed federally insured limits. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company regularly reviews the outstanding account receivable balances and makes estimates of the lifetime expected credit losses based upon consideration of factors such as the age of the receivable balance, historical experience, current economic conditions, and reasonable and supportable forecasts of future economic conditions. In addition, the Company periodically evaluates the financial condition of its clients to manage credit risk related to accounts receivable. As of December 31, 2021, two entities accounted for <span style="-sec-ix-hidden:Hidden_JO0t9UBrrEq19v3ATFcFew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">24%</span></span> and 11% each, or a combined 35% of total receivables. <span style="-sec-ix-hidden:Hidden_sp51vmRVQUu4M4VnkCAIuw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Two</span></span> entities accounted for 14% each, or a combined 28% total receivables as of December 31, 2020. </p>
CY2021Q4 pgny Concentration Risk Credit Risk Substantially All Cash Financial Institutions Number
ConcentrationRiskCreditRiskSubstantiallyAllCashFinancialInstitutionsNumber
1
CY2019 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
599000
CY2021 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2021 us-gaap Lease Practical Expedient Use Of Hindsight
LeasePracticalExpedientUseOfHindsight
true
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9500000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
9900000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
500621000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
344858000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
229683000
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
400000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-400000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7590000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5276000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2563000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1876000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5027000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3400000
CY2019 us-gaap Depreciation
Depreciation
700000
CY2020 us-gaap Depreciation
Depreciation
700000
CY2021 us-gaap Depreciation
Depreciation
700000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9500000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8901000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1213000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
99000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
599000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7805000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1231000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7419000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0429
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1286000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1286000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1326000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1407000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1407000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3400000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10112000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1462000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8650000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1231000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7419000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3440937
CY2021Q4 pgny Accrued Claims Payable Current
AccruedClaimsPayableCurrent
19998000
CY2020Q4 pgny Accrued Claims Payable Current
AccruedClaimsPayableCurrent
22799000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10089000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5087000
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
3092000
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1334000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1231000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1231000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
843000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1216000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2172000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2605000
CY2021Q4 pgny Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
37425000
CY2020Q4 pgny Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
34272000
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders.
CY2021 pgny Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2019Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
26659
CY2019Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.91
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
615980
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
615980
CY2019Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Incentive And Non Statutory Stock Options Exercise Price Percentage Of Fair Value Of Common Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIncentiveAndNonStatutoryStockOptionsExercisePricePercentageOfFairValueOfCommonStockMaximum
1
CY2020Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Incentive And Non Statutory Stock Options Exercise Price Percentage Of Fair Value Of Common Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIncentiveAndNonStatutoryStockOptionsExercisePricePercentageOfFairValueOfCommonStockMaximum
1
CY2021Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Incentive And Non Statutory Stock Options Exercise Price Percentage Of Fair Value Of Common Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIncentiveAndNonStatutoryStockOptionsExercisePricePercentageOfFairValueOfCommonStockMaximum
1
CY2019Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Ten Percent Ownership Of Common Stock Or Greater Exercise Price Percentage Of Fair Value Of Common Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTenPercentOwnershipOfCommonStockOrGreaterExercisePricePercentageOfFairValueOfCommonStockMaximum
1.10
CY2020Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Ten Percent Ownership Of Common Stock Or Greater Exercise Price Percentage Of Fair Value Of Common Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTenPercentOwnershipOfCommonStockOrGreaterExercisePricePercentageOfFairValueOfCommonStockMaximum
1.10
CY2021Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Ten Percent Ownership Of Common Stock Or Greater Exercise Price Percentage Of Fair Value Of Common Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTenPercentOwnershipOfCommonStockOrGreaterExercisePricePercentageOfFairValueOfCommonStockMaximum
1.10
CY2020Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Unvested Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedSharesSubjectToRepurchase
0
CY2021Q4 pgny Share Based Compensation Arrangement By Share Based Payment Award Unvested Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedSharesSubjectToRepurchase
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.93
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
500053000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5290216
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4160618
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5287341
CY2021 pgny Common Stock Capital Shares Reserved For Future Issuance Annual Increase Term
CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreaseTerm
P10Y
CY2021 pgny Common Stock Capital Shares Reserved For Future Issuance Annual Increase Percentage
CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercentage
0.04
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.41
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.60
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13384301
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.03
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.21
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
303639
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.56
CY2021 pgny Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled
5928
CY2021 pgny Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
9.15
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14924013
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.11
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
439557000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7343948
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.02
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
396496000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6694592
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
308893000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
175000000.0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
79600000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
50800000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.60
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.56
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.68
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
16000000.0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9300000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2800000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
164200000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
65769000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
46459000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8569000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89105562
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85722670
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
489067
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
25.47
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1517075
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
58.13
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
201916
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
26.48
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
38708
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
32.75
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1765518
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
53.25
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1560693
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1146000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
103677
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
481000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
21125
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
595000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
14505
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33706000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12821000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5061000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
65769000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
46459000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99055526
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8569000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89105562
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85722670
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20735202
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
11252485
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13332856
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100358047
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20735202
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20735202
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.74
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.54
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-31000
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1748576
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
769417
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13733323
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33300000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-37800000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
191000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-31000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
191000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
12000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-25154000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-28852000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-8149000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-9119000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-33303000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-37971000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33334000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-37780000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.25
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.38
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.06
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.99
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-1
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.56
CY2019 pgny Effective Income Tax Rate Reconciliation Warrant Valuation Percent
EffectiveIncomeTaxRateReconciliationWarrantValuationPercent
-0.45
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3.17
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.35
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.02
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.03
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.03
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-4.36
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.03
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-4.36
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
55180000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29291000
CY2021Q4 pgny Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
8000
CY2020Q4 pgny Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
11000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1039000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1039000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9133000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3241000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
5916000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
4116000
CY2021Q4 pgny Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
2297000
CY2020Q4 pgny Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
2475000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
164000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
154000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
414000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
195000
CY2020Q4 pgny Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Indirect Tax Accrual
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsIndirectTaxAccrual
313000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
74151000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40835000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
224000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
225000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
73927000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
40610000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
581000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
392000
CY2021Q4 pgny Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
2072000
CY2020Q4 pgny Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
2247000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2653000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2639000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
71274000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
37971000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-28500000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
397000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
7000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
390000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
81024000
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
64605000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
98928000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
100301000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
122133000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
128651000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
122284000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
127553000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64422000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
52650000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3355000
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4776000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
78092000
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
79635000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4014000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4028000
CY2020Q2 us-gaap Gross Profit
GrossProfit
11955000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4441000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
93226000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
99030000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
93792000
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
102438000
CY2020Q1 us-gaap Gross Profit
GrossProfit
16602000
CY2020Q3 us-gaap Gross Profit
GrossProfit
20836000
CY2020Q4 us-gaap Gross Profit
GrossProfit
20666000
CY2021Q1 us-gaap Gross Profit
GrossProfit
28907000
CY2021Q2 us-gaap Gross Profit
GrossProfit
29621000
CY2021Q3 us-gaap Gross Profit
GrossProfit
28492000
CY2021Q4 us-gaap Gross Profit
GrossProfit
25115000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3267000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3608000
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7696000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9904000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9419000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12653000
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14729000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13086000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13937000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14986000
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17607000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
13171000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
13027000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
16008000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
19505000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
17100000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
17965000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
19427000
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
25303000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3431000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1072000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4828000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1161000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11807000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11656000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9065000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-188000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
164000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-92000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-293000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
150000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17000
CY2020Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18000
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
252000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
144000
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
83000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
314000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6000
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
264000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52000
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-210000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3745000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1064000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4822000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1176000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11796000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11920000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9117000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-398000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
116000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-37896000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3370000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6807000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7679000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15478000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3629000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1064000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
4822000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
39072000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15166000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
18727000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
16796000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
15080000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84537538
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85281151
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86265297
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86514619
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87404287
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88165158
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89571226
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90537077
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99665158
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85281151
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98969588
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99021233
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100106497
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99808085
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100370331
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100321297

Files In Submission

Name View Source Status
0001558370-22-002466-index-headers.html Edgar Link pending
0001558370-22-002466-index.html Edgar Link pending
0001558370-22-002466.txt Edgar Link pending
0001558370-22-002466-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pgny-20211231.xsd Edgar Link pending
pgny-20211231x10k.htm Edgar Link pending
pgny-20211231x10k008.jpg Edgar Link pending
pgny-20211231x10k_htm.xml Edgar Link completed
pgny-20211231xex21d1.htm Edgar Link pending
pgny-20211231xex23d1.htm Edgar Link pending
pgny-20211231xex31d1.htm Edgar Link pending
pgny-20211231xex31d2.htm Edgar Link pending
pgny-20211231xex32d1.htm Edgar Link pending
pgny-20211231xex32d2.htm Edgar Link pending
pgny-20211231_cal.xml Edgar Link unprocessable
pgny-20211231_def.xml Edgar Link unprocessable
pgny-20211231_lab.xml Edgar Link unprocessable
pgny-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending